Tildrakizumab-asmn Subcutaneous and Trastuzumab Injection (Intravenous)
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Trastuzumab Injection (Intravenous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Trastuzumab Intravenous
- Tildrakizumab-asmn Subcutaneous-Trastuzumab-anns
- Tildrakizumab-asmn Subcutaneous-Trastuzumab-dkst
- Tildrakizumab-asmn Subcutaneous-Trastuzumab-dkst Intravenous
- Tildrakizumab-asmn Subcutaneous-Trasylol
- Tildrakizumab-asmn Subcutaneous-Travasol
- Trastuzumab Injection (Intravenous)-Tilia Fe
- Trastuzumab Injection (Intravenous)-Tiludronate
- Trastuzumab Injection (Intravenous)-Timentin
- Trastuzumab Injection (Intravenous)-Timentin Add-Vantage
- Trastuzumab Injection (Intravenous)-Timentin Injection
- Trastuzumab Injection (Intravenous)-Timentin Novaplus